Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.
Clinical trial NCT05563467 · RECRUITING
Trial details
- NCT number
- NCT05563467
- Sponsor
- Maria Sklodowska-Curie National Research Institute of Oncology
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-31
- Primary completion
- 2027-05-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.